Standard Biotools (LAB) Change in Acquisitions & Divestments (2011 - 2026)

Standard Biotools (LAB) has reported Change in Acquisitions & Divestments for 15 consecutive years, with $15.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 71.15% year-over-year to $15.0 million; the TTM figure through Mar 2026 stood at $142.0 million (down 50.87% YoY), while the FY2025 annual figure was $179.0 million, down 48.71% from the prior year.
• Change in Acquisitions & Divestments fell to $15.0 million in Q1 2026 per LAB's latest filing, from $25.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $127.0 million in Q2 2024 and bottomed at $12.0 million in Q3 2022.
• Historically, Change in Acquisitions & Divestments has averaged $51.0 million across 5 years, with a median of $49.0 million in 2024.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments soared 210.03% — and 2026, when it plunged 71.15%.
• Standard Biotools' Change in Acquisitions & Divestments stood at $41.0 million in 2022, then sank by 36.59% to $26.0 million in 2023, then jumped by 130.77% to $60.0 million in 2024, then tumbled by 58.33% to $25.0 million in 2025, then sank by 40.0% to $15.0 million in 2026.
• Business Quant data shows LAB's Change in Acquisitions & Divestments at $15.0 million in Q1 2026, $25.0 million in Q4 2025, and $54.0 million in Q3 2025.